Health ❯ Pharmaceuticals

Weight Management

Obesity Treatment GLP-1 Agonists Medications GLP-1 Drugs Injectable Drugs Obesity GLP-1 Medications GLP-1 Receptor Agonists GLP-1 Obesity Treatments

Kris Jenner Says Ozempic Made Her 'Really Sick' After Trial

Her first on-record admission ends years of speculation about celebrity weight-loss drugs.

Novo Nordisk Lifts Outlook After Wegovy Pill Fuels Q1 Beat

Rio Sets March 18 Launch for Public Semaglutide Care as Supplier Price Survey Opens

GLP-1 Boom Rewrites Menus as McDonald's Tests Protein-Forward Options

Eli Lilly Tightens GLP-1 Grip, Guides Up to $83 Billion for 2026

Serena Williams’ Super Bowl Zepbound Ad Draws Criticism Over Weight-Loss Pitch, Ro Connection

Eli Lilly’s GLP-1 Lead Faces New Pressure From Novo’s Weight-Loss Pill

Novo Nordisk Leans on Wegovy’s New MASH Indication and First Oral Obesity Pill to Rebound in 2026

FDA Clears Wegovy Pill, Handing Novo Nordisk a Short-Term Edge in Obesity-Drug Race

Laís Caldas’ Pregnancy Renews Warnings on Mounjaro’s Effect on Oral Contraceptives

Novo Nordisk Slashes Wegovy Price in India by Up to 37% to Take On Mounjaro

UK and Eli Lilly Unveil £85m Pilot for Pharmacy and Digital Delivery of Weight-Loss Injections

Delhi High Court Directs DCGI to Reassess Weight-Loss Drug Approvals Within Three Months

Sophia Umansky Defends Mounjaro Use Amid Hair Loss and Online Criticism

Rising Use of Ozempic Raises Health, Ethical, and Social Concerns

GLP-1 Drugs Show Promise Beyond Diabetes and Obesity but Raise Cost and Ethical Concerns